Fujifilm continues to expand its biologics CDMO business, ploughing further $850m into US and UK sites

Fujifilm continues to expand its biologics CDMO business, ploughing further $850m into US and UK sites

Submitted by admin on July 8, 2021 - 11:15am
Source: 
Biopharma Reporter
News Tags: 
Fujifilm
CMDOs
UK
drug manufacturing
Headline: 
Fujifilm continues to expand its biologics CDMO business, ploughing further $850m into US and UK sites
snippet: 

Fujifilm Corporation has made an additional US$850m investment to enable the expansion of its BIO-CMDO sites in the UK, at Billingham, and in the US.

Do Not Allow Advertisers to Use My Personal information